Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 22.05% vs 4.97% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -42.39% vs 123.17% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -6.75% vs 29.31% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -23.58% vs 20.45% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Haisco Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 17.18% vs 25.57% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 22.05% vs 4.97% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 102.55% vs 76.39% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -42.39% vs 123.17% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 5.17% vs 33.62% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -6.75% vs 29.31% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -2.41% vs -2.35% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -23.58% vs 20.45% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






